Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Arachidonate 5-lipoxygenase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma mansoni | lipoxygenase | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Schistosoma japonicum | ko:K00461 arachidonate 5-lipoxygenase [EC1.13.11.34], putative | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Schistosoma mansoni | lipoxygenase | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Schistosoma japonicum | IPR001024,Lipoxygenase, LH2;IPR013819,Lipoxygenase, C-terminal,domain-containing | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | casein kinase II, putative | 0.4221 | 1 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.0202 | 0.0248 | 0.0146 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.23 | 0.5338 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.23 | 0.5338 | 0.4586 |
Giardia lamblia | Kinase, CMGC CK2 | 0.4221 | 1 | 1 |
Plasmodium vivax | unspecified product | 0.4221 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.23 | 0.5338 | 0.4586 |
Echinococcus multilocularis | acetylcholinesterase | 0.0202 | 0.0248 | 0.0146 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.23 | 0.5338 | 0.4586 |
Trichomonas vaginalis | CMGC family protein kinase | 0.4221 | 1 | 1 |
Echinococcus granulosus | carboxylesterase 5A | 0.0202 | 0.0248 | 0.0146 |
Brugia malayi | casein kinase II, putaitve | 0.0672 | 0.1388 | 0.1169 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.23 | 0.5338 | 0.4586 |
Plasmodium vivax | casein kinase 2, alpha subunit, putative | 0.4221 | 1 | 1 |
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 0.23 | 0.5338 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.23 | 0.5338 | 0.4586 |
Loa Loa (eye worm) | casein kinase II | 0.0672 | 0.1388 | 0.1169 |
Trichomonas vaginalis | CMGC family protein kinase | 0.4221 | 1 | 1 |
Onchocerca volvulus | Casein kinase II subunit beta homolog | 0.23 | 0.5338 | 0.5 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.23 | 0.5338 | 0.4586 |
Echinococcus multilocularis | casein kinase ii subunit alpha | 0.4221 | 1 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.0202 | 0.0248 | 0.0146 |
Brugia malayi | Csnk2b protein | 0.23 | 0.5338 | 0.5219 |
Entamoeba histolytica | casein kinase, putative | 0.4221 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.23 | 0.5338 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.23 | 0.5338 | 0.4586 |
Schistosoma mansoni | casein kinase II beta subunit | 0.23 | 0.5338 | 0.5338 |
Trichomonas vaginalis | CMGC family protein kinase | 0.4221 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.23 | 0.5338 | 0.4586 |
Toxoplasma gondii | CMGC kinase, CK2 family | 0.4221 | 1 | 1 |
Echinococcus granulosus | casein kinase ii subunit beta | 0.23 | 0.5338 | 0.5289 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.23 | 0.5338 | 0.4586 |
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 0.23 | 0.5338 | 0.4586 |
Plasmodium falciparum | casein kinase 2, alpha subunit | 0.4221 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.4221 | 1 | 1 |
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 0.23 | 0.5338 | 0.4586 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0202 | 0.0248 | 0.0146 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.23 | 0.5338 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.23 | 0.5338 | 0.4586 |
Loa Loa (eye worm) | Csnk2b protein | 0.23 | 0.5338 | 0.5219 |
Echinococcus multilocularis | casein kinase ii subunit beta | 0.23 | 0.5338 | 0.5289 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.23 | 0.5338 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.23 | 0.5338 | 0.4586 |
Schistosoma mansoni | protein kinase | 0.4221 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.4221 | 1 | 1 |
Echinococcus multilocularis | acetylcholinesterase | 0.0202 | 0.0248 | 0.0146 |
Echinococcus granulosus | casein kinase ii subunit alpha | 0.4221 | 1 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.4221 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.4221 | 1 | 1 |
Loa Loa (eye worm) | CMGC/CK2 protein kinase | 0.4221 | 1 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0202 | 0.0248 | 0.0248 |
Trichomonas vaginalis | CMGC family protein kinase | 0.4221 | 1 | 1 |
Trypanosoma brucei | Casein kinase II | 0.4221 | 1 | 1 |
Leishmania major | casein kinase II, putative | 0.4221 | 1 | 1 |
Schistosoma mansoni | lipoxygenase | 0.0142 | 0.0104 | 0.0104 |
Giardia lamblia | Casein kinase II beta chain | 0.23 | 0.5338 | 0.4586 |
Onchocerca volvulus | Casein kinase II subunit beta homolog | 0.23 | 0.5338 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 30 mg kg-1 | Ex vivo inhibition of LTB4 production was measured in dog blood | ChEMBL. | 1848292 |
IC50 (functional) | = 3.1 uM | In vitro inhibition of LTB4 production was measured in rat blood | ChEMBL. | 1848292 |
IC50 (functional) | = 67 uM | In vitro inhibition of PGE-2 production was measured in rat blood | ChEMBL. | 1848292 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.